PharmaTalkRadio
435 episodes - English - Latest episode: 15 days ago - ★★★★ - 16 ratingsPharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Entrepreneur Data Scientist, Ben Liu on Solving Bottlenecks in Clinical Research
July 23, 2019 23:00 - 19 minutes - 17.3 MBTrialspark, CEO, Dr Ben Liu recently sat down with Valerie Bowling, Executive Director of DPharm in a podcast discussion. Valerie checked in with Ben on the progress of life as a data science entrepreneur. They also discussed how Ben and his team are solving big challenges in drug development, new evolving R&D models and more. On Sept 17th, Ben will be interviewing Pfizer's Rod Mackenzie, Chief Development Officer at DPharm: Disruptive Innovations to Advance Clinical Trials in Boston. For mo...
Stories from Bioinspiration to Innovation
July 22, 2019 13:30 - 28 minutes - 24.9 MBWhen developing technologies to solve medical problems, one often encounters significant hurdles, that at times seems insurmountable. In this discussion, recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Dr Jeffrey Karp, Professor of Medicine, Harvard Medical School and Director of the Laboratory for Accelerated Medical Innovation, Brigham and Women's Hospital discusses overcoming these hurdles with the use of nature for inspiration. This talk will expl...
Including Wellness in the Pharma Model - How Drug Delivery will be a Key Enabler
July 21, 2019 13:30 - 25 minutes - 22.1 MBIn this industry keynote recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference, Justin Wright, PhD, Global Head of Innovation, Novartis, discusses how the transformation from traditional drugs to next-generation product systems, where sometimes the drug is only a component of the overall product offering, is creating a opportunity for non-traditional competitors and start-ups to access the market and potentially redefine the value model associated with drug p...
Service & Patients in Clinical Trials
July 21, 2019 12:00 - 46 minutes - 41.8 MBIn this podcast from DPharm 2018, Chip Bell shows pragmatic ways to change our culture to support service-oriented thinking that benefits patients and investigators. The patient's expectations are being quickly changed today by disruptors far beyond the Pharma industry. How will the concept of service make us better at drug development and help us become more disruptive thinkers? Speaker: Chip Bell, PhD, Keynote Innovative Service Speaker, Author, Senior Partner, The Chip Bell Group The 9t...
Panel: Delivering mRNA Drugs and Vaccines – Progress and Future Outlook
July 20, 2019 15:00 - 37 minutes - 33.4 MBModerated by Marian Gindy, PhD, Executive Director, Discovery Pharmaceutical Sciences, Merck, this panel discussion recorded at the 8th annual Partnership Opportunities in Drug Delivery (PODD) conference explores how mRNA vaccines represent a promising alternative to conventional vaccine approaches for infectious diseases as well as oncology indications, including an emerging application for personalized cancer vaccines. The panelists for the session are: Örn Almarsson, PhD, Head of Formulat...
How to Innovate like Amazon to Modernize Clinical Trials
July 11, 2019 12:00 - 40 minutes - 36.6 MBThis session was presented at the 8th annual DPharm conference in September 2018. When Amazon announced that the creation of a new healthcare company with Berkshire Hathaway and JPMorgan Chase, the move signaled how the company is stepping into the healthcare industry. However, Amazon Web Services (AWS) has been working directly with the healthcare and life science industries for quite some time. Life Science Director, Mark Johnston, shares how AWS thinks about innovation, in particular for ...
Alzheimer’s Studies: Exploring Registries to Improve Enrollment & Trial Design
June 25, 2019 15:30 - 30 minutes - 26.7 MBRoughly, 5.7 million people in the U.S. are living with Alzheimer’s. Globally, an estimated 47 million individuals are living with dementia. There is no cure, and treatments can only relieve certain symptoms for some people. Research studies so far have a poor record. Patients can face incredible enrollment hurdles in clinical trials. A Patient Registry can be very useful in identifying patients. A registry can also address the original problem statement about failed trials. A robust, livin...
4th Annual IO Combinations 360°: What to Expect in 8 Minutes
May 23, 2019 14:00 - 8 minutes - 7.26 MBThis 8 minute podcast summarizes what you can expect at the 4th annual IO Combinations 360° conference. This conference provides the latest data impacting immuno-oncology combinations and patient treatment with perspectives from science, clinical and business. The conference takes place June 20-21, 2019 at the Wyndham Philadelphia Historic District, Philadelphia, PA. For more information please visit www.theconferenceforum.org or contact us at [email protected]
CAR-T Therapy: Optimization Through Engineering T-cells or Combinations
May 02, 2019 11:00 - 20 minutes - 17.5 MBDr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, Department of Medicine and Center for Cellular Immunotherapies (CCI), Perelman School of Medicine, University of Pennsylvania focuses on the next steps for CAR-T therapy for cancer, discussing the novel approaches that are being developing in Dr Carl June’s lab including CAR-T combinations with small molecules and gene-editing. Save the date for IO Combinations 360° happening J...
Combining IO Modalities In a Cost Effective, Patient Beneficial Manner
May 01, 2019 11:00 - 40 minutes - 35.9 MBThe hardest thing to figure out now is what interventions and combinations make the most sense in which patients and how to combine all these emerging modalities in a way that is cost effective, benefits patients and unfolds in our lifetime. There are hypothesis on what technologies should be explored together, however very few companies have all the relevant skills, reagents or product candidates in one setting, so it requires collaboration to generate the most powerful combinations and sequ...
IO Partnering Strategies In an Increasingly Complex Environment
April 30, 2019 11:00 - 52 minutes - 47.2 MBIn this panel, moderated by Dr Axel Hoos, GSK, individuals from large pharma and biotech business development leads discuss decision-making when it comes to partnering and collaborations in today’s IO environment. What is the current nature and types of partnerships being done in IO?Is dealmaking and partnerships evolving due to the need for IO combinations? How so?What is the balance between in house R&D and external innovation in IO?What is the decision making regarding exclusive licensing ...
Next Generation Biomarker and Companion Diagnostics for Predicting Response
April 29, 2019 18:00 - 39 minutes - 35 MBThis panel, moderated by Dr Priti Hegde, Genentech, discusses the following: How can biomarkers act as a tool for understanding the biology at a level that is sufficient for making decisions around combinations?What are the potential biomarkers that can help predict if a patient will respond to combinations?Once a biomarker is identified in terms of biology, been measured and the technology platform identified to meet those measures, how is the biomarker developed to the level of clinical gra...
Innovations in Immuno-Oncology Imaging
April 25, 2019 18:30 - 34 minutes - 30.5 MBIn this podcast, Dr Gregory Goldmacher, Executive Director, Translational Biomarkers and Head of Clinical Imaging, Merck Research Labs along with Dr Matthew Silva, Executive Vice President, Scientific Applications, Invicro discuss innovations in IO imaging. Together, Dr Goldmacher and Dr Silva address: The evolution of treatment response criteria in immuno-oncologyNovel Tracers: Monitoring tumor or immune cell populations with imagingRadiomics, AI and Digital Biomarkers Join us February 26...
2nd Annual Drug Delivery West - 5 Minute Overview
April 05, 2019 15:00 - 5 minutes - 4.26 MBThe 2nd annual Drug Delivery West (DDW) Summit provides a west coast venue for biotech, pharma and drug delivery companies to address scientific and business solutions for the best routes of delivery across different therapeutic areas with an emphasis on emerging technologies and to prepare for the future of R&D and clinical care. This podcast discusses who will be presenting and the topics covered at the summit taking place May 6-7, 2019 at the Marines' Memorial Club and Hotel in San Francis...
Modernizing Clinical Trials with IQVIA's Dr Cynthia Verst
April 01, 2019 17:30 - 25 minutes - 22.6 MBModernizing Clinical Trials with IQVIA's Dr Cynthia Verst Host: Valerie Bowling, Executive Director, Pharma Talk Radio and DPharm:Disrupting Clinical Trials Guest: Dr Cynthia Verst, President, Design and Delivery Innovation for the Research & Development Solutions organization at IQVIA
Integrating Care and Research with Dr Laura Esserman
March 27, 2019 09:00 - 8 minutes - 6.91 MBIn this podcast, Valerie Bowling, Executive Director of the Conference Forum, interviews Dr Laura Esserman, breast cancer surgeon and researcher at the University of California, San Francisco. Dr Esserman shares her thoughts on how we can move towards uniting care and clinical research and the future of how medicine should be practiced.
Drug Delivery Global Health Challenge
March 04, 2019 16:00 - 13 minutes - 11.1 MBThis discussion was presented at the inaugural Drug Delivery West conference in 2018. One of the key challenges in global health is ensuring safe and effective delivery of life saving interventions to remote and non-clinical settings. The Bill & Melinda Gates Foundation invests in technologies, which will help achieve this goal. Learn about an RFP they are launching to indentify new ideas for delivering lyophilized products and how you can participate. Presented by David Robinson, PhD, Depu...
Patient Perspectives on Drug Delivery Needs Present and Future
February 25, 2019 15:30 - 42 minutes - 38.4 MBThis panel, presented at the inaugural Drug Delivery West conference in 2018, provides patient perspectives on what they want from drug delivery technologies. These case examples provide insight that every technology can benefit from and lessons learned through our patient representatives. Co-Moderators: Valerie Bowling, Patient Advocate and Executive Director, Drug Delivery West Sudeshna Dutta Ray, Senior Engineer, Advanced Device Technology and Innovation, Amgen Panelists: Cynthia Gold...
What are the Regulatory and Ethical Concerns of Integrating Care and Research?
February 06, 2019 13:00 - 35 minutes - 31.9 MBIn this discussion, CRAACO co-chair, Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc, and Alison Bateman-House, PhD, MPH, MA, Assistant Professor Division of Medical Ethics, NYU Langone Health, consider what lines are being drawn in the integration of clinical care and clinical research. More specifically: Research and care or treatment are separate spheres in the regulatory and ethical worlds. What happens when they are brought together?Are there ethical barriers that need to...
How Can We Work with Medical Practices to Offer Patients Clinical Trials?
February 05, 2019 16:30 - 41 minutes - 37.4 MBIn this discussion, stakeholders from medical practices, hospitals, service providers, and patient advocacy discuss how medical practices can offer clinical trials to patients. Including: Infrastructure and supportHow to establish physician championsHow to influence leadership supportContacting patients Moderated by: Jennifer Byrne, Founder, Greater Gift Initative Panelists: Judy Hung, MD, Director Trial Innovation Unit, Division of Clinical Research, Massachusetts General Hospital Jeff Ja...
Why Are Clinical Trials Not Typically a Care Option?
February 05, 2019 15:30 - 45 minutes - 41.2 MBMurray Abramson, MD, VP Clinical Operations, Biogen and Jeff James, CEO, Wilmington Health, discuss the blockers and enablers to making clinical research a care option. Discuss includes: What are the blockers or conflicts (laws, culture, behaviors, etc) that prevent clinical research from becoming a care option?What is the difference between a movement and an initiative - how should be think about clinical research as a care option? Benefits?What are the enablers or requirements to incorporat...
How to Move Clinical Research into Communities That Would Truly Benefit
February 04, 2019 15:30 - 35 minutes - 31.8 MBJonathan Jackson, PhD, Director CARE Research Center, Massachusetts General Hospital, and Jim Kremidas, Executive Director, Association of Clinical Research Professionals (ACRP) sit down for a frank discussion on the benefits of offering clinical research in underserved communities. Many communities, whether affected by race, ethnicity, or socioeconomic lines, are underrepresented in clinical research. How can offering these care options enhance access to other resources in a broader sense an...
Lessons Learned from a Veteran Biotech and Investor MD
February 04, 2019 15:00 - 31 minutes - 27.5 MBChief Medical Officer Summit co-chair, Jim Roach, and prominent biotech investor, Elizabeth Stoner, sit down for a fireside chat to discuss what investors are seeking when investing in a biotech company, particularly traits of a Chief Medical Officer. Stoner shares her insights on longevity, key qualities of an effective CMO, and how her perspective as a biotech veteran and former director of clinical development across biopharma both large and small is affecting her investment decisions in t...
Case Study: Preparing for the Challenges of Late Stage Trials
February 01, 2019 15:00 - 31 minutes - 27.8 MBMark Currie, President of R&D at Ironwood Pharmaceuticals, shares his amazing journey driving a product from establishing the foundation for the discovery of linaclotide by Ironwood scientists and leading every aspect of linaclotide's development and regulatory review. He shares his thought processes, pressure points, and lessons learned in leading the R&D team to get a product successfully to market. For more information on the Chief Medical Officer Summit and details for the 7th annual pro...
Should Patients Have the Right to Try?
January 31, 2019 14:30 - 39 minutes - 35.2 MBIn this podcast, Dr Alison Bateman-House, Assistant Professor, Division of Medical Ethics at NYU Langone Health, discusses the debate of compassionate use and the right to try. It dives into the implications, both positive and negative, of opening up that door.
Best Practices in Communication and PR Strategy
January 30, 2019 14:30 - 26 minutes - 23.8 MBIn this podcast, Raju Joshi, Managing Partner at Clinical Partners Group and Dr Zain Kassam, CSO at Finch Therapeutics, discuss how CMO's can more effectively communicate with CEO's, CSO's, and Clinical Operations executives in order to prove a comprehensive summary of the science and business aspects of the company. You can join us at the 7th annual Chief Medical Officer Summit happening April 4-5, 2019 in Boston. To learn more visit theconferenceforum.org.
Translating Patient Insight and Patient Experience Internally into Deliverables
January 24, 2019 14:30 - 37 minutes - 33.4 MBMary Stober Murray, Associate Director, Diversity and Patient Engagement for BMS, discusses applying quality systems framework (structure, processes, outcomes) to patient engagement initiatives to help create clinical development deliverables that meet industry goals while aligning with patients needs. Mary Stober Murry will be joining the 6th annual Patients as Partners US program on March 11-12 at the Wyndham Philadelphia Historic District Hotel in Philadelphia to lead a roundtable discuss...
Progress and Future Outlook of Cancer Immunotherapy
January 23, 2019 15:30 - 29 minutes - 26.2 MBIn this podcast, we were joined by Mr Charles Graeber, award-winning journalist and author who recently published The Breakthrough: Immunotherapy and the Race to Cure Cancer along with Dr James Gulley, Head of the Immunotherapy Section and Director of the Medical Oncology Service at the Center for Cancer Research within the National Cancer Institute. Together Mr Graeber and Dr Gulley delved into the significance of this moment in science, what the progress has been and explore what is next o...
Panel: Engaging Patients By Giving Them their Data
January 22, 2019 15:00 - 31 minutes - 27.7 MBThis podcast features a panel previously recorded at the 5th annual Patients as Partners US program on Engaging Patients By Giving Them their Data. The panel, moderated by David Leventhal, Director of Clinical Innovation for Pfizer, discussed: • What information and data do patients want during a clinical trial? • What initiatives is pharma currently doing to support this? • What impact will it have if patients have access to their data? Additional panelists included: Jenny Ahlstrom, My...
Mobile Technology in Clinical Trials: Clinical Trials Transformation Initiative
January 15, 2019 14:30 - 36 minutes - 32.7 MBLes Jordan, Working Group Member and Cindy Geoghegan, Team Lead for CTTI, the Clinical Trials Transformation Initiative, share findings from a multi-stakeholder project undertaken by the Clinical Trials Transformation Initiative to better understand patient perspectives on mobile technologies in clinical trials. The survey, conducted amongst 100 patients across multiple therapeutic areas, evaluated the ways patients would be willing to use mobile technologies and the impact on their particip...
How GSK Implemented Pivotal End-to-End Engagement Initiatives at Different Stage
January 14, 2019 21:00 - 15 minutes - 13.6 MBDr Marilyn Metcalf, Head of the Center of Innovation for GSK, at the 5th annual Patients as Partners 2018 program. Dr Metcalf shares how GSK implemented pivotal end-to-end engagement initiatives at different stages of development. Dr Metcalf walked the audience through some examples of the engagement initiatives supported by: • Creation of a framework and toolkit that builds on existing infrastructure • Networks of champions and project leads • Project planning • Emerging best practices b...
How to Make Patient Involvement Sustainable Throughout Medicines Development
January 12, 2019 13:00 - 31 minutes - 27.6 MBTo prevent ticking off a box and to ensure that patient involvement is systemic and sustainable, we have to move into patient-centricity 2.0. What does this mean and how is this done so we can turn the patient voice into value, impact, and benefit? This session presented at the 2nd annual Patients as Partners EU meeting, which took place January 2018 in London, demonstrates best practices from Hoffman La Roche, Melanoma Patient Network, Patient Focused Medicines Development, and European Pat...
What Does a Truly Patient-Centered Healthcare System Look Like in 5-10 Years?
January 11, 2019 18:00 - 39 minutes - 35.4 MBWhat would have to change to make a patient-centric healthcare system a reality? How can this be achieved, given the huge resistance to change built into current systems? In this session, Alastair Kent, Director of Genetic Alliance UK, addresses: New opportunities to interveneDemographic changeConstrained funding right across EuropeThe introduction of Expert Reference NetworksHow we can work through this collaboratively. This session was presented at the 2nd annual Patients as Partners Europe...
6th Annual Patients as Partners US: What to Expect in 8 Minutes
January 09, 2019 14:30 - 8 minutes - 7.16 MBThis 8 minute podcast summarizes what you can expect at the 6th annual Patients as Partners US conference. This is the only event that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. The conference takes place March 11-12, 2019 at the Wyndham Philadelphia Historic District, Philadelphia, PA. The program is chaired by Merck's Jan Nissen, VP, Patient Innovation and Engagement, Arthritis Founda...
How Partnering with Medical Research Charities is Key to Medicines Development
January 09, 2019 13:00 - 47 minutes - 42.3 MBMedical research charities in the UK have been successfully integrating patient insight into their activities for over 10 years. In this session presented at the 2nd annual Patients as Partners Europe in January 2018, Claire Nolan, Research Involvement Manager, Parkinson's UK, and Chris MacDonald, Research Involvement Manager, Arthritis Research UK, explore a shift in attitiude towards pharmaceutical and medical research charity collaboration. They share how charities have developed their pro...
Patients as Partners Europe 3rd Annual What to Expect in 5 Minutes
December 24, 2018 06:00 - 6 minutes - 4.77 MBThis 5 minute podcast summarizes what you can expect at the 3rd annual Patients as Partners EU conference. It is the only event in Europe that demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research. It takes place January 28-29 at the Millennium Gloucester Hotel in the Kensington area of London. The program is co-chaired by GSK's Andrew Garvey, Global Patient Advocacy Lead and Servier's Dr Lode Dewulf, C...
How Tesaro is Integrating the Patient in the Clinical Development Process
December 12, 2018 12:00 - 26 minutes - 23.6 MBIn this talk from the 5th annual Patients as Partners US conference, Beth Zaharoff, Director, Patient-Focused Clinical Trial Engagement of Tesaro will walk the audience through how they integrated patient input throughout multiple stages of the development process. Other discussion points include: How Tesaro is working to eliminate some of the burdens inherent in clinical trial participationWhat patient focus means to Tesaro and why/how they decided to jump in the deep endTesaro focus groups...
Keytruda in Combo with Chemo in NSCLC
December 11, 2018 22:00 - 25 minutes - 22.7 MBOriginally recorded at the 4th annual Immuno-Oncology 360° 2018 event, Dr Corey Langer, Director, Thoracic Oncology and Professor of Medicine for the Perelman Center for Advanced Medicine at the University of Pennsylvania, discusses data on Keytruda in combination with chemotherapy in non-small cell lung cancer. This year, the University of Pennsylvania will be represented by Dr Marco Ruella, Assistant Professor and Scientific Director Lymphoma Program, Division of Hematology and Oncology, D...
Future Value Generation in Immuno-Oncology
December 05, 2018 12:30 - 1 hour - 54.9 MBIn this podcast, originally recorded at the 4th annual annual Immuno-Oncology 360° 2018 event, Dr Axel Hoos, SVP, Oncology R&D, GSK, led a panel on The Future Value Generation in IO. Dr Hoos was joined by expert analyst Dr Andrew Baum, Head of Global Healthcare and Managing Director of Equity Research for Citi along with Dr David Grayzel, Partner of Atlas Venture, Dr Simeon George, Partner of SR One and Mark Simon, Partner of Torreya Partners. Key discussion points included: What is the most ...
Reflections of the Cancer Moonshot and Future of the Biden Cancer Initiative
December 04, 2018 22:00 - 34 minutes - 30.9 MBGreg Simon, President at the Biden Cancer Initiative and Former Executive Director of the White House Cancer Task Force will reflect on the work of the Cancer Moonshot. Which provided the leadership to harness the millions of scientists and patients, powerful new therapies, and cultural changes needed to double our rate of progress against cancer. He will also provide a progress report on the Biden Cancer Initiative which is now continuing this movement to double our rate of progress in pre...
Balancing Benefit and Toxicity from Immunotherapeutics
December 04, 2018 18:30 - 48 minutes - 43.7 MBJeffrey Weber, Deputy Director at Laura and Isaac Perlmutter Cancer Center and Co-director of Melanoma Program and Head of Experimental Therapeutics at NYU Langone Medical Center, discusses the day to day management of, and the science around, IO adverse events that may help us understand how these drugs work. Including: The need to educate physicians about management of immune related adverse events with increasing penetration of checkpoint inhibitors into the communityThe relationship of th...
The BioCentury Report on Immuno-Oncology Industry Trends
November 28, 2018 19:30 - 23 minutes - 20.5 MBThe BioCentury Report on Industry Trends covers how companies and academic investigators are driving innovations within immuno-oncology, including new targets, modalities and technologies, to address some of the field's biggest challenges. Some topics include: The broadening trend to harness the innate and adaptive arms of the immune system for immunotherapiesNew cell types beyond CAR-T and traditional T-cellsCombination strategies for neoantigens and other targets from the earliest stages of...
5th Annual Immuno-Oncology 360˚: 12 minutes of What to Expect
November 19, 2018 06:30 - 13 minutes - 11.8 MBIO360° brings together science, clinical and business under one roof to accelerate treatments to fight a wider range of cancers. This brief podcast gives you an overview on what you can expect at IO360°. The three-day summit features 10 plenary sessions with over 80 speakers and includes ten plus hours of networking. There will be over 450 attendees. Key benefits: Access to KOLs driving the sciencePartnership opportunities with all stakeholders in Immuno-OncologyPresentations on the latest ...
Partnership Opportunities in Drug Delivery 2018: What to Expect 5 Min Podcast
September 08, 2018 09:00 - 6 minutes - 4.91 MBThe 8th Annual Partnership Opportunities in Drug Delivery (PODD) event will take place on October 18-19, 2018. PODD is designed with 3 purposes: To present a strategic level program for pharma and biotech biz development professionals with a thorough overview of the latest drug delivery technologies available along with an update on deals and opportunities.To provide drug delivery with a platform to present their technologies and get the latest insights on what the delivery and formulation ne...
Podcast: From a Zimbabwean Village Kid to a PhD Regenerative Medicine Student
August 30, 2018 13:30 - 27 minutes - 24.4 MBCan you imagine coming from a family of 21 kids in a small remote village in Africa with no running water or electricity and one day a snake bite changes your entire future and you end up a PhD student in WInston-Salem, NC? In this remarkable story, our guest Goodwell Nzou, PhD candidate in molecular medicine at the Institute at Wake Translation Science tells Valerie Bowling, Executive Director, the Conference Forum how he went from a village kid to an amputee to a band member that led him t...
All of Us Research Program, a Nation-wide Initiative from the NIH
August 17, 2018 05:00 - 19 minutes - 16.5 MBPodcast guest, Elise Felicione, who is currently a Scientific Collaborator at the Scripps Translational Science Institute is playing an integral role under the direction of Dr Eric Topol on a nation-wide initiative from the NIH. The initiative is called All Of Us, a US Precision Medicine program that aims to enroll a million Americans and follow them for 10 years, during which time participants will contribute biological, environmental, and lifestyle data. One-third of participants will part...
Reimagining Clinical Trials with Entrepreneur, Dr Ben Liu, CEO, Trialspark
August 17, 2018 04:00 - 22 minutes - 19.9 MBDuring his graduate work, Dr Benjamine Liu observed the many bottlenecks that get in the way of clinical trials slowing the development of new treatments for patients. This challenge inspired him to launch Trialspark. Trialspark partners with doctors to create FDA compliant trial sites within their existing practices (like Airbnb), unlocking the 98% of patients and doctors not involved in trials today and democratizing access to research treatments. In this podcast discussion with Ben, we d...
Blockchain Opportunities for Patient Data Donation and Clinical Research
August 16, 2018 16:30 - 31 minutes - 27.6 MBPatients are at the center of research and their data is the foundation for clinical innovation. However, significant barriers exist that inhibit the secure and efficient sharing of patient data. In this podcast, Craig Lipset, Head of Clinical Innovation, Pfizer, Munther Barra, Head of New Clinical Paradigm, Pfizer and Aditya Kudumala, Principal, Deloitte discuss blockchain as a catalyst to significantly change how we can access and use data to improve patient lives. Where is the patient data...
DPharm Podcast: What to Expect at the 2018 Event in 8 Minutes
August 16, 2018 04:30 - 9 minutes - 7.76 MBThis 8 minute podcast gives you an overview on what to expect from the 8th annual DPharm conference. DPharm is the annual event in the US to get the best access to innovative ideas, especially disruptive ones, to advance clinical trials with a view to reducing the burden to patients and investigators. DPharm 2018 is dedicated to all things digital, data science, patient data ownership and new approaches to optimize clinical operation systems. DPharm is September 25-26 at the Boston Marriott...
Mobile in Clinical Trials Podcast: 3 1/2 Minutes on What to Expect
August 15, 2018 05:00 - 4 minutes - 3.31 MBWelcome to the 5th annual Mobile in Clinical Trials podcast. In this quick fire podcast, you will get a brief overview on what to expect. The conference takes place in Boston on Sept 24th, the day before DPharm. It is researched and produced by the Conference Forum and is chaired by: Daniel Karlin, MD Assistant Professor of Psychiatry, Tufts University and Former Head of Clinical, Informatics, and Regulatory Strategy, Digital Medicine, Pfizer Inc Mobile and digital tools are the future of ...